Introduction
============

The plants of the Genus *Epimedium*, also known as "Yin-Yang-Huo", were used in traditional Chinese medicine and are believed to invigorate the kidney and enhance the "Yang". For more than one thousand years, some plants of *Epimedium* have been widely used in China to treat cardiovascular diseases, amnesia, arthritis, asthenia, impotence, infertility, lumbago and other chronic illnesses \[[@R1]--[@R2]\]. Icariin (**1**), a 3,7-diglycosylflavone ([Fig. 1](#F1){ref-type="fig"}), is recognized as the major pharmacologically active ingredient of these plants \[[@R3]--[@R4]\], and has been used as the index for quality control of the herbs and relative drug preparations \[[@R5]\]. Icariin, icariside I (**2**), and their aglycone, icaritin (**3**) ([Fig. 1](#F1){ref-type="fig"}), possess multiple biological activities, such as anti-oxidative \[[@R6]\], anti-inflammatory \[[@R7]\], anti-osteoporotic \[[@R8]\], anticancer \[[@R9]\], neuroprotective \[[@R10]\], angiogenesis stimulating \[[@R11]\], testosterone mimetic \[[@R12]\], antidepressant-like \[[@R13]\] and multidrug resistance reversal \[[@R14]\] activities.

![Structures of icariin (**1**), icariside I (**2**) and icaritin (**3**).](Beilstein_J_Org_Chem-11-1220-g002){#F1}

Although icariin exerts a variety of important bioactivities, reports concerning its synthesis are very scarce. One Chinese patent reported a 15-step total synthesis of icariin from benzyl alcohol with 0.6% overall yield \[[@R15]\]. The 11-step synthesis of icaritin, starting from 2,4,6-trihydroxyacetophenone via microwave-assisted Claisen rearrangement reaction as the key step, was succeeded with an overall yield of 23% \[[@R16]\]. In view of the long synthetic routes, tedious work-up and harsh reaction conditions, an alternative access to icariin (**1**) and related compounds is demanded for large-scale production and practical application.

Our interest in flavonoids with activities such as estrogen biosynthesis regulation and PDE inhibition, prompted us to seek for a practically synthetic approach to icariin. Previously our group prepared icaritin from phloroglucin through an Algar--Flynn--Oyamada reaction and europium-promoted prenylation \[[@R17]\]. However, a number of challengable problems such as strict conditions, numerous byproducts and poor yields, were calling for our continuous efforts to overcome these hitches \[[@R18]\]. As a continuation of this program, herein we report a new approach to icaritin and then icariin through semi-synthesis from the commercially available natural product kaempferol. Our previously developed regioselective methylation of kaempferol \[[@R19]\], Europium(III)-catalyzed *para*-Claisen--Cope rearrangement and the bis-glycosylation are the key features of this linear synthesis. Previously, we succeeded in the selective methylation of 4′-OH in kaempferol. In this work, we focus on developing an efficient procedure for the selective prenylation of flavonols for facile access to icariin (**1**).

Results and Discussion
======================

Our synthetic approach to **1** commenced with the preparation of aglycone **3**, as illustrated in [Scheme 1](#C1){ref-type="fig"}. First, 7-*O*-benzylkaempferide (**6**) was easily obtained from kaempferol through tetraacetylation, followed by benzylation at C-7 and selectively methylation, according to our previously developed procedure \[[@R19]\]. In order to methylate exclusively the 4′-OH in kaempferol, we initially attempted to use methoxymethyl (MOM) as 7-OH protecting group, but this method could not provide an ideal yield in the 4′-OH selective methylation and in subsequent Claisen--Cope rearrangement.

![Reagents and conditions: (a) Ac~2~O, pyridine, 94%; (b) BnBr, KI, K~2~CO~3~, acetone, 85%; (c) Me~2~SO~4~, K~2~CO~3~, acetone, MeOH, 82%; (d) MOMCl, *N*,*N*-diisopropylethylamine (DIPEA), CH~2~Cl~2~, 93%; (e) 3,3-dimethylallyl bromide, 18-crown-6, K~2~CO~3~, acetone, 86%; (f) Eu(fod)~3~, NaHCO~3~, PhCl, 85 °C, 61%; (g) MeOH, 3 M HCl (aq), reflux, 95%; (h) Pd/C, 1,4-cyclohexadiene, MeOH, 84%.](Beilstein_J_Org_Chem-11-1220-g003){#C1}

The resulting free 3-OH in **6** is protected with an orthogonal protecting group to give 3-*O*-methoxymethyl-4′*-O*-methyl-7-*O*-benzylkaempferol (**7**) in 93% yield. Then introduction of a requisite prenyl ether moiety at C-5 of **7**, with 3,3-dimethylallyl bromide in the presence of potassium carbonate and 18-crown-6, formed **8**, whose all hydroxy groups were protected for the rearrangement accompanied in the next step. It is noticeable that this compound is slightly less stable in solution, easily decomposing into **7** and **11** ([Scheme 2](#C2){ref-type="fig"}), especially under acidic conditions.

![Decomposition of **8**.](Beilstein_J_Org_Chem-11-1220-g004){#C2}

The Claisen rearrangement is commonly accepted as an efficient method for the preparation of *C*-isopentenyl. In the case of flavonoids, control of the regioselectivity of *ortho* (C6*)*/*para* (C8*)-*rearranged products is still remained a challenging issue \[[@R20]\]. Once the prenyl ether **8** was obtained, attention was fastened on the *para*-Claisen--Cope rearrangement to acquire the 8-prenylated product. Two pathways have been developed for the rearrangement: direct heating at about 217 °C \[[@R17],[@R21]\] and heating at about 60 °C in the presence of Eu(fod)~3~ \[[@R22]--[@R23]\]. When we adapted the former path, reflux of **8** in *N*,*N*-diethylaniline for 3 h led to complete consumption of **8** and gave an intractable product mixture, probably due to the prevalence of the 5-*O*-prenyl chain elimination with no rearrangement. Then we turned to try the latter method with 10 mol % Eu(fod)~3~ as the catalyst at 60 °C in dry CHCl~3~ ([Table 1](#T1){ref-type="table"}), in which the Claisen rearrangement of **8** indeed took place. Unlike reported results \[[@R24]--[@R26]\], we obtained the *ortho*-rearranged product, which was not the 6-(1,1-dimethylallyl) product **12a**, but an inseparable epimeric mixture of the dihydrofuro-flavonol **12**, presumably resulted from the cyclization of the 6-(1,1-dimethylallyl) chain with the 5-hydroxy group ([Scheme 3](#C3){ref-type="fig"}). The ratio of the *para*-rearranged product **9** to **12** was 0.7:1. When PhCl was used as solvent, the rearrangement of **8** at 85 ºC for 24 h allowed the isolation of **9** and **12** in a 0.9:1 ratio ([Table 1](#T1){ref-type="table"}). Although the proportion of **9** and the total yield were improved, the *para/ortho-*selectivity was still unsatisfactory, even when prolonging the reaction time to 36 h or raising the temperature to 100 °C. By carefully investigating the two routes in [Scheme 3](#C3){ref-type="fig"}, we assumed that an appropriate base is in favor of the \[1,5\]H σ migration in route 2, as well as lowering the acidity of Eu(fod)~3~ to prevent **12b** from cyclization in route 1, and therefore enhances the proportion of the *para-*rearrangement product **8**. Obviously, strong alkali could lead to heterocycle cleavage of the flavonoid skeleton. Gratifyingly, when prenyl ether **8** was treated with catalytic amounts of Eu(fod)~3~ and NaHCO~3~ in PhCl at 85 °C for 24 h ([Table 1](#T1){ref-type="table"}), the Claisen *para*-rearranged product was obtained selectively in 61% yield with the ratio **9** to **12** of 2.1:1. With other bases such as K~2~CO~3~ or DIPEA, the results were very different, probably due to the partial inactivity of Eu(fod)~3~ under these conditions. It is noteworthy that NaHCO~3~ only affected the **9**/**12** ratio, but not the total amount of *C*-isoprenoid flavonols **9** and **12**, which was found to stay around 90%. This to some extent, implies that our hypothesis on using appropriate base to hinder the Route 1 and to promote the Cope rearrangement step from C-6 to C-8 could be true. Therefore, the combination of Eu(fod)~3~ and NaHCO~3~ is preferable for the Claisen--Cope rearrangement from 5-*O*- to 8-*C*-prenyl products.

###### 

Rearrangement of 5-*O*-prenylflavone **8**.

  ---------------------------- ---------- --------- ------------------------- -------------------- ----------------------
  Method^a^                    *T* (ºC)   *t* (h)   Products (%)^b^           Ratio **9**:**12**   Total **9** + **12**
                                                                                                   
  CHCl~3~, Eu(fod)~3~          60         24        **9** (33), **12** (46)   0.7:1                79%
  PhCl, Eu(fod)~3~             85         24        **9** (42), **12** (47)   0.9:1                89%
  PhCl, Eu(fod)~3~, NaHCO~3~   85         24        **9** (61), **12** (29)   2.1:1                90%
  ---------------------------- ---------- --------- ------------------------- -------------------- ----------------------

^a^Eu(fod)~3~: 10 mol %; NaHCO~3~: 100 mol %. ^b^Isolated yield.

![Claisen rearrangement of flavonol **8**.](Beilstein_J_Org_Chem-11-1220-g005){#C3}

Exposure of compound **9** to dilute methanolic HCl at reflux resulted in the cleavage of the methoxymethyl group, giving rise to 7-*O*-benzylicaritin (**10**). Removal of the benzyl group in **10** resulting in **3** without affecting the double bond of the prenyl residue was another challenge. The hydrogenation of **10** with H~2~--Pd/C using EtOAc/MeOH (1:1) as solvent at 10 °C for 3 h, followed by column chromatography and recrystallization, provided **3** in 39% yield along with a large amount of the byproduct with reduced double bond. Then we tried a transfer hydrogenolysis method using ammonium formate/10% Pd/C \[[@R27]\], but the result was not improved. The desired product icaritin (**3**) was finally obtained in 84% yield from **10** when we used 1,4-cyclohexadiene/10% Pd/C in MeOH \[[@R28]\]. Hence, we optimized a convenient eight-step sequence from kaempferol to **3** through regioselective methylation and a domino Claisen--Cope rearrangement that delivered **3** in 26% overall yield. The NMR spectra of synthetic **3** (see [Supporting Information File 1](#SD1){ref-type="supplementary-material"} for experimental and spectral data) were in accordance with the reported ones \[[@R16],[@R29]\].

With icaritin (**3**) in hand, the selective glycosylation was investigated ([Scheme 4](#C4){ref-type="fig"}). The alkylation of OH in kaempferol followed a specific reactivity order: 7 \> 4′ \> 3 \>\> 5 \[[@R19]\]. We initially attempted the 7-OH glycosylation with tetra-*O*-acetylglucopyranosyl bromide (**15**) \[[@R30]\] as the donor and SrCO~3~ or AgNO~3~ as an activator in pyridine or quinoline \[[@R15],[@R31]\], but it was unsuccessful. TLC monitoring revealed that most of icartin was still unreacted even prolonging the reaction time to 48 h. To our delight, switching the solvent to DMF/CHCl~3~ and the activator to Ag~2~CO~3~ made the reaction to proceed smoothly, resulting in the synthesis of **13**. The yellow powder **13** was treated with tri-*O*-acetylrhamnopyranosyl bromide (**16**) \[[@R30]\] in CH~2~Cl~2~ using Ag~2~O as activator, following a known procedure \[[@R32]\]. Compound **14** was easily separated by normal silica gel column chromatography, with a yield of 31% from **3**.

![Reagents and conditions: (a) **15**, DMF/CHCl~3~, Ag~2~CO~3~, molecular sieves (4 Å, powder); (b) **16**, CH~2~Cl~2~, Ag~2~O, molecular sieves (4 Å powder), 31% for 2 steps; (c) NH~3~ (g), MeOH, 94%; (d) NH~3~ (g), MeOH, 63% for 2 steps.](Beilstein_J_Org_Chem-11-1220-g006){#C4}

The final procedure in completing the synthesis of icariin (**1**) is the removal of all acetyl groups in **14** ([Scheme 4](#C4){ref-type="fig"}). In contrast to the traditional method for deacetylation under basic conditions such as with CH~3~ONa \[[@R15]\] or K~2~CO~3~ \[[@R33]\] in CH~3~OH, employing methanolic ammonia (7.0 M) for 3 h at room temperature effectively suppressed the cleavage of the sugar moiety \[[@R34]\] and gave the target compound **1** in high conversion. Icariside I (**2**) was also obtained using the same procedure from compound **13**. Thus, icariin (**1**) and icariside I (**2**) were synthesized from kaempferol with 7% and 16% overall yields, respectively.

The compounds **14**, **2** and **1** were fully characterized by ESI-HRMS, ^1^H NMR, ^13^C NMR, ^1^H,^1^H COSY, ^1^H,^13^C HMBC/HSQC and IR (see [Supporting Information File 1](#SD1){ref-type="supplementary-material"} for experimental and spectral data). In icariin (**1**), the configurations of the anomeric C-atoms of rhamnose and glocuse were α and β on the basis of the anomeric proton signals at δ 5.27 and 5.00 with *J* = 1.3 Hz and 7.4 Hz, respectively. The NMR data of icariin (**1**) were in agreement with those reported \[[@R29],[@R35]\] and with the spectra of the authentic, naturally derived sample.

Conclusion
==========

In conclusion, we have developed an efficient and practical procedure for the preparation of the pharmacologically important compounds icariin (**1**) and icariside I (**2**) from kaempferol with 7% and 16% overall yields, respectively. The addition of NaHCO~3~ to the Eu(fod)~3~-catalyzed Claisen--Cope rearrangement could inhibit the formation of the *ortho*-cyclized rearrangement product, thus selectively promoting the *para*-Claisen--Cope rearrangement of flavonoid 5-prenyl ether*.* This procedure could afford facile access to the derivatives of icariin (**1**) and other structurally related flavonoid analogues.
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======================

###### 

Experimental section and copies of NMR, ESI-HRMS, HMBC, HSQC, COSY and NOESY spectra.
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